Remy Niman

Statistics

Publications

Citations

174

H-Index

Active since

2022

Affiliations

St Vincent's Hospital Sydney(Current)

The Kinghorn Cancer Centre

Theranostics (New Zealand)

The University of Sydney

Garvan Institute of Medical Research

Remy Niman is an author at St Vincent's Hospital Sydney specializing in therapy response assessment, metastatic castration-resistant prostate cancer, and medicine.

Publications per year

2022–2023

Publications

177Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing177Lu-PSMA-I&T Therapy

Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker et al. · Journal of Nuclear Medicine · 2022 · 70 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Evaluation of177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)

Sarennya Pathmanandavel, Megan Crumbaker, Bao Ho et al. · Journal of Nuclear Medicine · 2022 · 60 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

The Prognostic Value of Posttreatment68Ga-PSMA-11 PET/CT and18F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with177Lu-PSMA-617 and NOX66 in a Phase I/II Trial (LuPIN)

Sarennya Pathmanandavel, Megan Crumbaker, Andrew Nguyen et al. · Journal of Nuclear Medicine · 2022 · 31 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Prediction of 177Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on 68Ga-DOTATATE PET/CT

Hwan Lee, Sarit T. Kipnis, Remy Niman et al. · Cancers · 2023 · 13 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

1–4 of 4